FDA Drugs (New Approvals & NDA)Original article
Advancing Generic Drug Development: Leveraging Model-Integrated Evidence (MIE) in the Development & Approval of Generic Drugs - 08/27/2026
ConferenceNeutral
AI Analysis
Summary
FDA-focused workshop on advancing generic drug development through Model-Integrated Evidence (MIE), featuring expert presentations and Q&A sessions on regulatory considerations in generic drug approval.
Importance:2/10
Sentiment:
0.00
generic drugsregulatoryModel-Integrated EvidenceworkshopFDA
Read the original article
Published by FDA Drugs (New Approvals & NDA) on August 27, 2026 8:00 PM